Literature DB >> 19709840

Molecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyr.

Alicia Gomez-Lopez1, Dinorah Pan, Isabel Cuesta, Ana Alastruey-Izquierdo, Juan L Rodriguez-Tudela, Manuel Cuenca-Estrella.   

Abstract

Candida kefyr has been increasingly associated with bloodstream infections. This study reports on the identification and antifungal susceptibility pattern of 33 Candida isolates, identified biochemically as C. kefyr. One strain was finally identified as Candida sphaerica (Kluyveromyces lactis) by ITS sequencing. Both species seem to be emerging pathogens and highly susceptible in vitro to currently licensed antifungal compounds.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19709840     DOI： 10.1016/j.diagmicrobio.2009.06.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  8 in total

1.  Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.

Authors:  Janet F Staab; Dionysios Neofytos; Peter Rhee; Cristina Jiménez-Ortigosa; Sean X Zhang; David S Perlin; Kieren A Marr
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

2.  The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.

Authors:  Laurence Delhaes; Sébastien Monchy; Emilie Fréalle; Christine Hubans; Julia Salleron; Sylvie Leroy; Anne Prevotat; Frédérick Wallet; Benoit Wallaert; Eduardo Dei-Cas; Telesphore Sime-Ngando; Magali Chabé; Eric Viscogliosi
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Candidiasis caused by Candida kefyr in a neonate: case report.

Authors:  Stefan Weichert; Konrad Reinshagen; Katrin Zahn; Gernot Geginat; Annebärbel Dietz; Anna Kristina Kilian; Horst Schroten; Tobias Tenenbaum
Journal:  BMC Infect Dis       Date:  2012-03-18       Impact factor: 3.090

4.  Colonization of the bovine uterus by Candida kefyr.

Authors:  Cecilia Christensen Karstrup; Bent Aalbæk; Kirstine Klitgaard; Tim Kåre Jensen; Hanne Gervi Pedersen; Jørgen Steen Agerholm
Journal:  Acta Vet Scand       Date:  2017-09-16       Impact factor: 1.695

Review 5.  Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature.

Authors:  Anastasia Spiliopoulou; Fevronia Kolonitsiou; Georgia Vrioni; Stamatia Tsoupra; Alexandra Lekkou; Fotini Paliogianni
Journal:  J Mycol Med       Date:  2021-12-23       Impact factor: 3.746

6.  Two missense mutations, E123Q and K151E, identified in the ERG11 allele of an azole-resistant isolate of Candida kefyr recovered from a stem cell transplant patient for acute myeloid leukemia.

Authors:  Célia Couzigou; Frédéric Gabriel; Nicolas Biteau; Valérie Fitton-Ouhabi; Thierry Noël; Isabelle Accoceberry
Journal:  Med Mycol Case Rep       Date:  2014-05-09

7.  Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation.

Authors:  Sang Hu Kim; Shawn T Clark; Anuradha Surendra; Julia K Copeland; Pauline W Wang; Ron Ammar; Cathy Collins; D Elizabeth Tullis; Corey Nislow; David M Hwang; David S Guttman; Leah E Cowen
Journal:  PLoS Pathog       Date:  2015-11-20       Impact factor: 6.823

8.  Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.

Authors:  Suhail Ahmad; Ziauddin Khan; Noura Al-Sweih; Wadha Alfouzan; Leena Joseph; Mohammad Asadzadeh
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.